Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer

NCT00003832 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

NIH

Sponsor class

Conditions

Stage I Prostate Cancer
Stage IIA Prostate Cancer
Stage IIB Prostate Cancer

Interventions

DRUG: bromodeoxyuridine
PROCEDURE: conventional surgery
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)